Mark J. Poznansky

Mark J. Poznansky's AcademicInfluence.com Rankings

Mark J. Poznansky

Chemistry

#5754

World Rank

#6976

Historical Rank

Organic Chemistry

#1043

World Rank

#1176

Historical Rank

chemistry Degrees

Mark J. Poznansky

Biology

#9516

World Rank

#12731

Historical Rank

Immunology

#1082

World Rank

#1110

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Why Is Mark J. Poznansky Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mark J. Poznansky is a research scientist, science administrator and science blogger. He is the past president and CEO of the Ontario Genomics Institute and was previously chair of the board of OGI, and the founder of G2G Consulting Inc. He is a member of the Order of Canada, a member of the Order of Ontario and was CEO, president and scientific director of Robarts Research Institute.

(See a Problem?)

Mark J. Poznansky's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Biological approaches to the controlled delivery of drugs: a critical review. (1984) (394)
Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. (1993) (195)
Transbilayer movement of cholesterol in dipalmitoyllecithin–cholesterol vesicles (1976) (73)
Transbilayer movement of cholesterol in phospholipid vesicles under equilibrium and non-equilibrium conditions. (1978) (71)
Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent. (1982) (64)
Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. (1992) (62)
Comparison of the enzyme kinetics and immunological properties of catalase immobilized by microencapsulation and catalase in free solution for enzyme replacement (1974) (61)
Bilirubin Toxicity in Neural Cell Lines N115 and NBR10A (1985) (56)
Transmembrane movement of cholesterol in human erythrocytes. (1977) (48)
Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by changes in microsomal cholesterol content or phospholipid composition. (1987) (46)
Characterization of the ZO-1 protein in endothelial and other cell lines. (1990) (45)
Semipermeable aqueous microscapsules. Artificial cells. V. Permeability characteristics. (1968) (42)
Cholesterol transfer between lipid vesicles. Effect of phospholipids and gangliosides. (1988) (40)
Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). (1993) (37)
A modified tetramethylbenzidine method for measuring lipid hydroperoxides. (1990) (34)
Effect of surface curvature on the rate of cholesterol transfer between lipid vesicles. (1988) (34)
The effects of ischemia and ischemia-reperfusion on bacterial translocation, lipid peroxidation, and gut histology: studies on hemorrhagic shock in pigs. (1992) (34)
Bilirubin Toxicity in a Neuroblastoma Cell Line N-115:1. Effects on Na+K+ ATPase, [3H]- Thymidine Uptake, L-[35S]-Methionine Incorporation, and Mitochondrial Function (1989) (34)
Effect of microwave radiation (2450 MHz) on the active and passive components of 24Na+ efflux from human erythrocytes. (1982) (33)
Oxidation of spin trap 5,5-dimethyl-1-pyrroline-1-oxide in an electron paramagnetic resonance study of the reaction of methemoglobin with hydrogen peroxide. (1994) (32)
Insulin: carrier potential for enzyme and drug therapy. (1984) (30)
Lipid peroxidation inactivates rat liver microsomal glycerol-3-phosphate acyl transferase. Effect of iron and copper salts and carbon tetrachloride. (1990) (29)
Cholesterol exchange as a function of cholesterol/phospholipid mole ratios. (1979) (29)
Enzyme replacement therapy in fibroblasts from a patient with cholesteryl ester storage disease (1989) (25)
Curvature and composition-dependent lipid asymmetry in phosphatidylcholine vesicles containing phosphatidylethanolamine and gangliosides. (1989) (25)
Bilirubin diffusion through lipid membranes. (1986) (25)
IMMUNOGENICITY AND ANTIGENICITY OF SOLUBLE CROSS-LINKED ENZYME/ALBUMIN POLYMERS: ADVANTAGES FOR ENZYME THERAPY (1978) (25)
Growth hormone‐albumin conjugates Reduced renal toxicity and altered plasma clearance (1988) (24)
Cholesterol movement between human skin fibroblasts and phosphatidylcholine vesicles. (1982) (23)
Effect of FCCP on tight junction permeability and cellular distribution of ZO-1 protein in epithelial (MDCK) cells. (1990) (18)
Enhanced anti-inflammatory effect and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin (1980) (16)
Enzyme-protein conjugates: new possibilities for enzyme therapy. (1983) (16)
Liposomes: a new approach to gold therapy? (1979) (15)
Bilirubin Toxicity in a Neuroblastoma Cell Line N-115: II. Delayed Effects and Recovery (1989) (15)
Low density lipoprotein receptors on epithelial cell (Madin-Darby canine kidney) monolayers. Asymmetric distribution correlates with functional difference. (1991) (15)
α-1,4-Glucosidase–albumin polymers : in vitro properties and advantages for enzyme replacement therapy (1980) (13)
Antibody-mediated targeting of alpha-1,4-glucosidase-albumin polymers to rat hepatocytes. A model for enzyme therapy. (1981) (13)
Cholesterol-mediated regulation of HMG-CoA reductase in microsomes from human skin fibroblasts and rat liver. (1990) (12)
Bilirubin-neural cell interaction: characterization of initial cell surface binding leading to toxicity in the neuroblastoma cell line N-115. (1990) (12)
The effect of non-receptor-mediated uptake of cholesterol on intracellular cholesterol metabolism in human skin fibroblasts. (1985) (12)
Transendothelial Movement of Liposomes In Vitro Mediated by Cancer Cells, Neutrophils or Histamine (2004) (11)
Superoxide dismutase: improving its pharmacological properties by conjugation with human serum albumin. (1989) (11)
Neonatal jaundice and bilirubin encephalopathy: a clinical and experimental reappraisal. (1992) (10)
In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy. (1979) (10)
[50] Soluble enzyme-albumin conjugates: New possibilities for enzyme replacement therapy (1988) (9)
Membrane electrical properties of developing fast‐twitch and slow‐tonic muscle fibres of the chick. (1984) (8)
Lysophospholipid induced volume changes in lysosomes and in lysosomal lipid dispersions. (1974) (8)
Enzyme—Albumin polymers (1984) (7)
Low density lipoprotein binding induces asymmetric redistribution of the low density lipoprotein receptors in endothelial cells. (1999) (7)
Perspectives of Soluble Cross-Linked Enzyme Polymers for Enzyme Therapy (1977) (6)
Targeting Enzyme Albumin Conjugates Examining the Magic Bullet a (1987) (6)
Transbilayer movement of 24Na in sonicated phosphatidylcholine vesicles exposed to frequency-modulated microwave radiation. (1981) (4)
Soluble enzyme--albumin conjugates: new possibilities for enzyme replacement therapy. (1988) (3)
Chemical synthesis of 3-ethylcompactin, an inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A reductase (1990) (3)
Enzyme-albumin polymers. New approaches to the use of enzymes in medicine. (1984) (1)
alpha1,4-Glucosidase-albumin polymers: in vitro properties and advantages for enzyme replacement therapy. (1980) (1)
alpha-Glucosidase-albumin conjugates: effect of chronic administration in mice. (1985) (1)
Lipid vesicle-mediated alterations of membrane cholesterol levels: Effects on Na+ and K+ currents in squid axon (2005) (1)
1518 3H BILIRUBIN UPTAKE IN NEUROBLASTOMA CELLS (N115) (1985) (1)
Successful management of sequential pulmonary infections in a cardiac transplant recipient. (1990) (1)
News from the International Union for Pure and Applied Biophysics (1969) (0)
Issue Information (2020) (0)
1510 BILIRUBIN TOXICITY OF NEURAL CELLS IN CULTURE (1985) (0)
Infections – Intestines (2009) (0)
Advantagesin the Useof L-AsparaginaseAlbuminPolymeras an Antitumor Agent1 (2006) (0)
Use of a Two Chamber Culture Apparatus to Examine Transendothelial movement of liposomes in vitro (1995) (0)
News from the International Union for Pure and Applied Biophysics (1971) (0)
Chemical Synthesis of 3-Ethylcompactin (VI), an Inhibitor of 3-Hydroxy-3-methylglutarylcoenzyme A Reductase. (1990) (0)
Dr. Poznansky responds (1992) (0)
Issue Information (2020) (0)

This paper list is powered by the following services:

Other Resources About Mark J. Poznansky

en.wikipedia.org

What Schools Are Affiliated With Mark J. Poznansky?

Mark J. Poznansky is affiliated with the following schools:

Mark J. Poznansky's Academic­Influence.com Rankings

Why Is Mark J. Poznansky Influential?

Mark J. Poznansky's Published Works

Published Works

Other Resources About Mark J. Poznansky

What Schools Are Affiliated With Mark J. Poznansky?

Image Attributions

Mark J. Poznansky's AcademicInfluence.com Rankings